Emmaus Life Sciences (EMMA) Receivables - Net (2010 - 2026)
Emmaus Life Sciences (EMMA) reported Receivables - Net of $709,000 for Q2 2026, down 65.8% from $2.07 million a year earlier and down 65.4% from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences posted Receivables - Net of $2.8 million, up 6.9% from FY2024.
- Receivables - Net has a five-year compound annual growth rate of 69.9% (FY2020 to FY2025).
- By year, Receivables - Net came in at $2.62 million in FY2024 (-52.5%), $5.52 million in FY2023, $375,000 in FY2022 (-63.9%) and $1.04 million in FY2021 (+425.3%).
- The Q2 2026 figure ranks as the lowest quarterly Receivables - Net since Q4 2022.
- Year over year, Receivables - Net gained in two of the last eight quarters, with an average decline of 29.7%.
- The high point for year-over-year Receivables - Net in five years was Q4 2021 (growth of 425.3%); the low point was Q2 2026 (a decline of 65.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.05 million (Q1 2026), $2.8 million (Q4 2025) and $2.62 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Emmaus Life Sciences | 3.51 Mn | -2.79 Mn | 5.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 709,000.00 |
| Mar 31, 2026 | 2.05 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 2.62 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 2.62 Mn |
| Sep 30, 2024 | 4.94 Mn |
| Jun 30, 2024 | 4.60 Mn |
| Mar 31, 2024 | 2.99 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 5.57 Mn |
| Mar 31, 2023 | 2.20 Mn |
| Dec 31, 2022 | 375,000.00 |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 938,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 2.66 Mn |
API Access
Emmaus Life Sciences Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();